Loading clinical trials...
Loading clinical trials...
The goal of this research study is to learn if a support group program is acceptable for patients with prostate cancer or patients with breast cancer. Researchers also want to learn if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program. Support group programs will be conducted separately for prostate cancer patients and breast cancer patients.
Screening Questionnaires: Signing this consent form does not mean that you will be able to take part in this study. You will complete some questions about your mood to help researchers decide if you are eligible to take part in this study. It will take 10 to 15 minutes to complete these questions. The researcher will discuss the questionnaire results with you and provide you with a list of community referrals and resources. If your responses to the questions show that you are distressed, you will be eligible to take part in this study. If your responses to the questions show that you are not distressed, you will be randomly selected (as in the flip of a coin) to take part in this study. If your responses to the questions show that you may harm yourself, a licensed psychologist will follow-up with you and make recommendations for future treatment. Study Questionnaires: If you are found to be eligible and are selected to take part in this study, you will be asked to complete questionnaires that will have questions about your medical history, quality of life, mood, thought processes, methods of coping with the disease, and support that you receive from others. It will take about 1 hour to complete these questionnaires. Support Groups: You will also take part in a support group program for either prostate or breast cancer patients. Each support group will be made up of about 10 members. Each group will meet 1 time each week for 10 weeks. Each meeting will last about 2 hours. At each meeting, patients will discuss and learn about methods of coping with the disease and ways to relax. All meetings will be audio-recorded. Recordings will be reviewed by the research team to make sure that the groups are covering the program content. Length of Study: You will be on study for about 3 months. End-of Study Questionnaires: After the last support group meeting, you will complete questionnaires that will ask questions about your medical history, quality of life, mood, thought processes, methods of coping with the disease, and support that you receive from others. You will be off study after you have completed the end-of-study questionnaires. This is an investigational study. Up to 240 patients will take part in this study. Up to 204 will be enrolled at MD Anderson.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
May 1, 2009
Primary Completion Date
March 26, 2019
Completion Date
March 26, 2019
Last Updated
May 15, 2019
240
ESTIMATED participants
Group Meetings
BEHAVIORAL
Questionnaire
BEHAVIORAL
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494